Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate whether Biaxin (clarithromycin) improves sputum abnormalities, lung function, and overall feeling of well-being in people with cystic fibrosis (CF). Biaxin is ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Wake Forest University
Collaborators
NCT04469439 · Chronic Rhinosinusitis (Diagnosis), Cystic Fibrosis
NCT04530383 · Cystic Fibrosis-related Diabetes, Cystic Fibrosis
NCT06154447 · Cystic Fibrosis
NCT05422222 · Cystic Fibrosis
NCT06984679 · Cystic Fibrosis (CF), Cystic Fibrosis in Children
Wake Forest University Health Sciences
Winston-Salem, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions